The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: This study examined the association between a history of heavy alcohol use and smoking, presence of the apolipoprotein‐E epsilon 4 allele (APOE ε4), and age of disease onset in a community dwelling sample of 685 Alzheimer's disease (AD) patients spanning three ethnic groups. Design: Cross‐sectional study of AD patients evaluated at a University‐affiliated outpatient memory disorders clinic. Subjects: A clinic‐based cohort of white non‐Hispanic (WNH; n = 397), white Hispanic (WH; n = 264), and African‐American (AA; n = 24) patients diagnosed with possible or probable AD according to NINCDS‐ADRDA diagnostic criteria. Measurements: The age of onset of AD was obtained from a knowledgeable family member. All patients were assessed for APOE genotype. History of alcohol and tobacco consumption prior to the onset of dementia was obtained via an interview with the patient and the primary caregiver. A history of heavy drinking was defined as >2 drinks per day and a history of heavy smoking was defined as ≥1 pack per day. Results: Presence of an APOE ε4 allele, a history of heavy drinking, or a history of heavy smoking were each associated with an earlier onset of AD by 2–3 years. Patients with all three risk factors were likely to be diagnosed with AD nearly 10 years earlier than those with none of the risk factors. Conclusion: The results suggest that APOE ε4 and heavy drinking and heavy smoking lower the age of onset for AD in an additive fashion. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“AD currently affects an estimated 5 million Americans (Alzheimer’s Association, 2007) and the number of people suffering from this disease is expected to grow to over 13 million by the year 2050 (Hebert et al., 2003).”
BackgroundClinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378
Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study
Tyas, S. L., White, L. R., Petrovitch, H., Webster Ross, G., Foley, D. J., Heimovitz, H. K., & Launer, L. J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00156-2 · Cited by 226
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“For example, the e4 allele of the apolipoprotein gene located on chromosome 19 (APOE) is overrepresented in AD cases compared to age-matched controls (Farrer et al., 1997).”
BackgroundAPOE and other loci affect age‐at‐onset in Alzheimer's disease families with PS2 mutation
Wijsman, E. M., Daw, E. W., Yu, X., Steinbart, E. J., Nochlin, D., Bird, T. D., & Schellenberg, G. D. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30087 · Cited by 79 · cited 1×
“Even in those individuals in which a PS2 mutation has caused an autosomal dominant form of AD, APOE has further modified the age of onset in a similar dose-dependent way (Wijsman et al., 2005).”
BackgroundAlzheimer's disease and smoking: bias in cohort studies
Debanne, S. M., Bielefeld, R. A., Cheruvu, V. K., Fritsch, T., & Rowland, D. Y. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11308 · Cited by 20
Cited by
Ritchie, K., Carriere, I., Ritchie, C. W., Berr, C., Artero, S., & Ancelin, M.-L. (2010) · BMJ · doi:10.1136/bmj.c3885 · Cited by 250
“whereas heavy drinking may lower the age of onset of Alzheimer’s disease.”
BackgroundGene–environment interactions in Alzheimer disease: the emerging role of epigenetics
Migliore, L., & Coppedè, F. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00714-w · Cited by 217
Moderate alcohol consumption and cognitive risk
Neafsey, E., & Collins, M. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s23159 · Cited by 205
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
The impact of alcohol on Alzheimer's disease: A systematic review
Piazza-Gardner, A. K., Gaffud, T. J. B., & Barry, A. E. (2013) · Aging & Mental Health · doi:10.1080/13607863.2012.742488 · Cited by 94
Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy
Nehls, M. (2016) · Journal of Molecular Psychiatry · doi:10.1186/s40303-016-0018-8 · Cited by 41
“the onset of AD is on average 10 years earlier [502].”
BackgroundLogue, M. W., Miller, M. W., Sherva, R., Zhang, R., Harrington, K. M., Fonda, J. R., Merritt, V. C., Panizzon, M. S., Hauger, R. L., Wolf, E. J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12870 · Cited by 35
Waris, S., Patel, A., Ali, A., & Mahmood, R. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-08044-4 · Cited by 33
“AA produced due to heavy alcohol drinking is also associated with cancer, brain tissue damage, cognitive dysfunction and early onset of neurodegenerative diseases such as Alzheimer’s (Harwood et al. 2010; Yan et al. 2016; Boffetta and Hashibe 2006; Setshedi et al. 2010).”
BackgroundLoss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70486 · Cited by 12
Metadata
- Authors
- Harwood, D. G., Kalechstein, A., Barker, W. W., Strauman, S., St. George‐Hyslop, P., Iglesias, C., Loewenstein, D., & Duara, R.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2009-09-14
- Volume
- 25
- Issue
- 5
- Pages
- 511-518
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W1993641707
- Cited by
- 112
- References
- 6
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.